Esta web utiliza cookies propias y de terceros para mejorar nuestros servicios mediante el análisis de sus hábitos de navegación. Si continua navegando, consideramos que acepta su uso. Puede cambiar la configuración u obtener más información aquí.

About IMI
  • Partner Login
  • Contact us
  • Site map
logo
  • About PRECISESADS
    • Project Structure
    • Project Governance
    • Expected Impact
  • Partners
  • News & Media
  • Events
  • Publications
  • Patients
    • Information for Patients
    • List of Patients associations
  • Useful links

Useful links

  • Home
  •  
  • Useful links
  • Project Support
  • Related Projects
  • Scientific Information
  • Innovative Medicines Initiative (IMI)
  • European Federation of Pharmaceutical Industries and Associations (EFPIA)
  • European Commission Research & Innovation
  • AETIONOMY
    Organising mechanistic knowledge about neurodegenerative diseases for the improvement of drug development and therapy
  • Nature Genetics
    • IMI
    • European Union
    • EFPIA

    This website reflects only the author’s views and neither IMI nor the European Commission are liable for any use that may be made of the information contained therein.

    PRECISESADS receives support from the Innovative Medicines Initiative Joint Undertaking under grant agreement n° [115565], resources of which are composed of financial contribution from the European Union’s Seventh Framework Programme (FP7/2007-2013) and EFPIA companies’ in kind contribution.

PRECISESADS

Molecular Reclassification to Find Clinically Useful Biomarkers for Systemic Autoimmune Diseases

  • P. T. Ciencias de la Salud Avda. de la Ilustración 114
    Telf. +34 958 715 500 (ext 202)
  • 18016 Granada, Spain
    Fax +34 958 637 071
  • [email protected]
  • Cookie policy
  • Personal data
© Copyright - Precisesads. All rights reserved.
Top